Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,
about
Lipoamide Channel-Binding Sulfonamides Selectively Inhibit Mycobacterial Lipoamide DehydrogenaseEmerging Approaches to Tuberculosis Drug Development: At Home in the Metabolome.[Better search strategies, hopeful candidates. The search for new antimycobacterial drugs].VapC toxins from Mycobacterium tuberculosis are ribonucleases that differentially inhibit growth and are neutralized by cognate VapB antitoxins.A genomic scale map of genetic diversity in Trypanosoma cruzi.The tuberculosis drug discovery and development pipeline and emerging drug targets.Reconstitution of a Mycobacterium tuberculosis proteostasis network highlights essential cofactor interactions with chaperone DnaK.Advances In Mycobacterium Tuberculosis Therapeutics Discovery Utlizing Structural Biology.Tuberculosis drug discovery and emerging targets.New structural classes of antituberculosis agents.Kunkel Lecture: Fundamental immunodeficiency and its correction.Rational design of drug-like compounds targeting Mycobacterium marinum MelF protein.Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier.Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes.Lipoamide dehydrogenase is essential for both bloodstream and procyclic Trypanosoma brucei.
P2860
Q27680644-78BAE3F6-EA8C-4FF1-BE02-66544A45D561Q30236042-5C2E3727-A59D-4C90-920D-8CBEE796AE69Q30318128-E335DAE4-757B-432E-BC1C-6A61C0E538B2Q33955336-609D928B-72A0-40E8-ADF1-3B4B3F3EA92FQ34523989-F4EC5991-5719-4851-B3D5-53D4C2C83AD0Q35664209-D7E13653-9AD5-466F-9ED7-662F9B96A476Q37493185-1678FFDB-438C-4E79-AA75-E8D0A22F72B6Q38061197-C65D279A-AA02-43A4-B695-7CB10A107450Q38219605-EC586CEC-4081-48B1-A3C1-B47403DC14C1Q39362128-D31AAE38-72BD-470D-B653-B0EC19FA1639Q39431238-753FF2D6-68B2-43BD-BA3E-58A7EAC804EDQ40066304-EB2F0A6D-9808-4E65-A771-80DF33555C4EQ41845465-5A556477-531D-4E91-A607-E2C616B330B7Q41907887-336A6D62-2F63-49AB-97BA-4E3E2CC0E042Q44219810-D07F5E0A-EEF6-438D-975A-14897C861551
P2860
Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Triazaspirodimethoxybenzoyls a ...... erial Lipoamide Dehydrogenase,
@ast
Triazaspirodimethoxybenzoyls a ...... erial Lipoamide Dehydrogenase,
@en
Triazaspirodimethoxybenzoyls a ...... erial Lipoamide Dehydrogenase,
@nl
type
label
Triazaspirodimethoxybenzoyls a ...... erial Lipoamide Dehydrogenase,
@ast
Triazaspirodimethoxybenzoyls a ...... erial Lipoamide Dehydrogenase,
@en
Triazaspirodimethoxybenzoyls a ...... erial Lipoamide Dehydrogenase,
@nl
prefLabel
Triazaspirodimethoxybenzoyls a ...... erial Lipoamide Dehydrogenase,
@ast
Triazaspirodimethoxybenzoyls a ...... erial Lipoamide Dehydrogenase,
@en
Triazaspirodimethoxybenzoyls a ...... erial Lipoamide Dehydrogenase,
@nl
P2093
P2860
P356
P1433
P1476
Triazaspirodimethoxybenzoyls a ...... erial Lipoamide Dehydrogenase,
@en
P2093
Aditya Venugopal
Carl Nathan
Christopher D Lima
J David Warren
Mulchand S Patel
Nancy Arango
Ruslana Bryk
Yun-Hee Park
P2860
P304
P356
10.1021/BI9016186
P407
P577
2010-03-02T00:00:00Z